Modelling Quarantine Effects on SARS-CoV-2 Epidemiological Dynamics in Chilean Communes and Their Relationship with the Social Priority Index

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2023 Mar 16

PMID 36923504

Authors

Dino G Salinas

M Leonor Bustamante

Mauricio O Gallardo

Affiliations

Soon will be listed here.

Abstract

Background: An epidemiological model (susceptible, un-quarantined infected, quarantined infected, confirmed infected (SUQC)) was previously developed and applied to incorporate quarantine measures and calculate COVID-19 contagion dynamics and pandemic control in some Chinese regions. Here, we generalized this model to incorporate the disease recovery rate and applied our model to records of the total number of confirmed cases of people infected with the SARS-CoV-2 virus in some Chilean communes.

Methods: In each commune, two consecutive stages were considered: a stage without quarantine and an immediately subsequent quarantine stage imposed by the Ministry of Health. To adjust the model, typical epidemiological parameters were determined, such as the confirmation rate and the quarantine rate. The latter allowed us to calculate the reproduction number.

Results: The mathematical model adequately reproduced the data, indicating a higher quarantine rate when quarantine was imposed by the health authority, with a corresponding decrease in the reproduction number of the virus down to values that prevent or decrease its exponential spread. In general, during this second stage, the communes with the lowest social priority indices had the highest quarantine rates, and therefore, the lowest effective viral reproduction numbers. This study provides useful evidence to address the health inequity of pandemics. The mathematical model applied here can be used in other regions or easily modified for other cases of infectious disease control by quarantine.

References

Wallinga J, Lipsitch M . How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci. 2007; 274(1609):599-604. PMC: 1766383. DOI: 10.1098/rspb.2006.3754. View

Castillo A, Parra B, Tapia P, Lagos J, Arata L, Acevedo A . Geographical Distribution of Genetic Variants and Lineages of SARS-CoV-2 in Chile. Front Public Health. 2020; 8:562615. PMC: 7536338. DOI: 10.3389/fpubh.2020.562615. View

Villalobos Dintrans P, Castillo C, de la Fuente F, Maddaleno M . COVID-19 incidence and mortality in the Metropolitan Region, Chile: Time, space, and structural factors. PLoS One. 2021; 16(5):e0250707. PMC: 8101927. DOI: 10.1371/journal.pone.0250707. View

Saure D, ORyan M, Torres J, Zuniga M, Santelices E, Basso L . Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study. Lancet Infect Dis. 2021; 22(1):56-63. PMC: 8428469. DOI: 10.1016/S1473-3099(21)00479-5. View

Cumsille P, Rojas-Diaz O, Moisset de Espanes P, Verdugo-Hernandez P . Forecasting COVID-19 Chile' second outbreak by a generalized SIR model with constant time delays and a fitted positivity rate. Math Comput Simul. 2021; 193:1-18. PMC: 8480140. DOI: 10.1016/j.matcom.2021.09.016. View

Mena G, Martinez P, Mahmud A, Marquet P, Buckee C, Santillana M . Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile. Science. 2021; 372(6545). PMC: 8158961. DOI: 10.1126/science.abg5298. View

Wang Z, Tang K . Combating COVID-19: health equity matters. Nat Med. 2020; 26(4):458. DOI: 10.1038/s41591-020-0823-6. View

Howard J, Huang A, Li Z, Tufekci Z, Zdimal V, van der Westhuizen H . An evidence review of face masks against COVID-19. Proc Natl Acad Sci U S A. 2021; 118(4). PMC: 7848583. DOI: 10.1073/pnas.2014564118. View

Canals M, Cuadrado C, Canals A, Yohannessen K, Lefio L, Bertoglia M . Epidemic trends, public health response and health system capacity: the Chilean experience in four months of the COVID-19 pandemic. Rev Panam Salud Publica. 2020; 44:e99. PMC: 7429930. DOI: 10.26633/RPSP.2020.99. View

10.

Chen T, Rui J, Wang Q, Zhao Z, Cui J, Yin L . A mathematical model for simulating the phase-based transmissibility of a novel coronavirus. Infect Dis Poverty. 2020; 9(1):24. PMC: 7047374. DOI: 10.1186/s40249-020-00640-3. View

11.

Yang C, Wang J . A mathematical model for the novel coronavirus epidemic in Wuhan, China. Math Biosci Eng. 2020; 17(3):2708-2724. PMC: 7376496. DOI: 10.3934/mbe.2020148. View

12.

Synowiec A, Szczepanski A, Barreto-Duran E, Lie L, Pyrc K . Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev. 2021; 34(2). PMC: 7849242. DOI: 10.1128/CMR.00133-20. View

13.

Mallah S, Ghorab O, Al-Salmi S, Abdellatif O, Tharmaratnam T, Iskandar M . COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob. 2021; 20(1):35. PMC: 8129964. DOI: 10.1186/s12941-021-00438-7. View

14.

Grudlewska-Buda K, Wiktorczyk-Kapischke N, Walecka-Zacharska E, Kwiecinska-Pirog J, Buszko K, Leis K . SARS-CoV-2-Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis. J Clin Med. 2021; 10(9). PMC: 8125301. DOI: 10.3390/jcm10091962. View

15.

Fisman D, Khoo E, Tuite A . Early epidemic dynamics of the west african 2014 ebola outbreak: estimates derived with a simple two-parameter model. PLoS Curr. 2015; 6. PMC: 4169344. DOI: 10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571. View

16.

Ashcroft P, Lehtinen S, Bonhoeffer S . Test-trace-isolate-quarantine (TTIQ) intervention strategies after symptomatic COVID-19 case identification. PLoS One. 2022; 17(2):e0263597. PMC: 8836351. DOI: 10.1371/journal.pone.0263597. View

17.

Ridenhour B, Kowalik J, Shay D . Unraveling R0: considerations for public health applications. Am J Public Health. 2013; 104(2):e32-41. PMC: 3935673. DOI: 10.2105/AJPH.2013.301704. View

18.

Byrne A, McEvoy D, Collins A, Hunt K, Casey M, Barber A . Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases. BMJ Open. 2020; 10(8):e039856. PMC: 7409948. DOI: 10.1136/bmjopen-2020-039856. View

19.

Kerr C, Mistry D, Stuart R, Rosenfeld K, Hart G, Nunez R . Controlling COVID-19 via test-trace-quarantine. Nat Commun. 2021; 12(1):2993. PMC: 8137690. DOI: 10.1038/s41467-021-23276-9. View

20.

Zhao S, Chen H . Modeling the epidemic dynamics and control of COVID-19 outbreak in China. Quant Biol. 2020; 8(1):11-19. PMC: 7095099. DOI: 10.1007/s40484-020-0199-0. View